Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TRVI | US
0.23
1.64%
Healthcare
Biotechnology
30/06/2024
15/04/2026
14.27
14.02
14.33
13.77
Trevi Therapeutics Inc. a clinical-stage biopharmaceutical company focuses on the development and commercialization of Haduvio for the treatment of serious cough conditions targeting the central and peripheral nervous systems. The company is developing Haduvio an oral extended-release formulation of nalbuphine which is in phase 2b/3 clinical trial for the treatment of chronic pruritus chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven Connecticut.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
46.9%1 month
52.8%3 months
61.9%6 months
61.7%-
-
3.42
0.02
0.02
-4.92
-
-
-43.03M
1.04B
1.04B
-
-
-
-
-48.09
3.46
3.34
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
3.06
Range1M
4.08
Range3M
4.51
Rel. volume
0.56
Price X volume
10.42M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| VIRIDIAN THERAPEUTICS ORS INC | VRDN | Biotechnology | 14.88 | 1.14B | -2.04% | n/a | 3.96% |
| MoonLake Immunotherapeutics | MLTX | Biotechnology | 18.02 | 1.13B | -4.05% | n/a | 0.64% |
| Monte Rosa Therapeutics Inc | GLUE | Biotechnology | 18.23 | 1.12B | 4.17% | n/a | 19.74% |
| Recursion Pharmaceuticals Inc. Class A Common Stock | RXRX | Biotechnology | 3.75 | 1.09B | 5.93% | n/a | 15.38% |
| AbCellera Biologics Inc | ABCL | Biotechnology | 3.86 | 1.09B | 2.66% | n/a | 6.49% |
| Vor Biopharma Inc | VOR | Biotechnology | 15.6 | 1.07B | -1.70% | n/a | 34.48% |
| Biohaven Pharmaceutical Holding Company Ltd | BHVN | Biotechnology | 10.37 | 1.05B | -0.67% | n/a | 7.75% |
| Cronos Group Inc | CRON | Biotechnology | 2.72 | 1.04B | 5.84% | n/a | 0.19% |
| Geron Corporation | GERN | Biotechnology | 1.69 | 1.02B | -4.52% | n/a | 28.38% |
| Certara Inc. | CERT | Biotechnology | 6.15 | 989.47M | 5.67% | n/a | 29.96% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Winnebago Industries Inc | WGO | Recreational Vehicles | 31.65 | 916.43M | -5.10% | 22.53 | 56.33% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.34 | 776.02M | -4.64% | 11.62 | 116.21% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 6.03 | 696.93M | 1.86% | 65.18 | 77.00% |
| Fox Factory Holding Corp | FOXF | Recreational Vehicles | 16.7 | 696.11M | -5.11% | 42.05 | 64.69% |
| Ennis Inc | EBF | Building Products & Equipment | 21.4 | 556.48M | -1.70% | 13.28 | 2.28% |
| Malibu Boats Inc | MBUU | Recreational Vehicles | 24.76 | 494.97M | -6.32% | n/a | 1.50% |
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 21.96 | 364.70M | -2.18% | 34.27 | 26.82% |
| Camping World Holdings Inc | CWH | Recreational Vehicles | 6.86 | 309.59M | -4.72% | n/a | 3644.76% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.2 | 306.55M | 1.91% | n/a | 174.23% |
| Marine Products Corporation | MPX | Recreational Vehicles | 7.6 | 263.85M | -0.91% | 13.23 | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -4.92 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 3.42 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 61.93 | - | Par |
| Debt to Equity | 0.02 | -1.23 | Expensive |
| Debt to Assets | 0.02 | 0.25 | Cheaper |
| Market Cap | 1.04B | - | Emerging |